Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNY1 pseudogene 3 (RNY1P3) is a human pseudogene closely related to RNY1, which encodes a Ro60-associated Y RNA involved in noncoding ribonucleoprotein complexes. RNY1P3 is classified as a noncoding RNA pseudogene, meaning it shares high sequence similarity with the functional RNY1 gene but is considered nonfunctional in terms of encoding a mature, active RNA or protein product[5][7][11]. Located on chromosome 13, RNY1P3 does not code for any functional proteins, and no validated role as a receptor, enzyme, transporter, or other typical drug target is described in the literature. Pseudogenes in general may act as molecular "sponges" for microRNAs or other regulatory RNAs, potentially influencing gene expression indirectly[6][9]; however, such functions for RNY1P3 specifically have not been experimentally substantiated. There are currently no therapeutics or clinical biomarkers involving RNY1P3, and it is not regarded as a druggable target[5][7][11].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNY1 pseudogene 3 (RNY1P3).